StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Hemogenyx Pharmaceuticals Plc
LSE:HEMO.L
Sector
Industries
Location
Market Cap
USD 10.96 M
Share Price
USD 2.38
Avg Daily Volume
31,506
Change (1 day)
-0.78%
Change (1 year)
13,962.26%
Change (YTD)
-52.93%
Hemogenyx Pharmaceuticals Plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2024: USD 6.37 M
Hemogenyx Pharmaceuticals Plc Selling, General, and Administrative Expenses (SG&A) is USD 6.37 M for the year ending December 31, 2024, a 1.83% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
-
Hemogenyx Pharmaceuticals Plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2023 was USD 6.25 M, a 448.85% change year over year.
-
Hemogenyx Pharmaceuticals Plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2022 was USD 1.14 M, a -39.75% change year over year.
-
Hemogenyx Pharmaceuticals Plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2021 was USD 1.89 M, a 120.39% change year over year.
-
Hemogenyx Pharmaceuticals Plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2020 was USD 857.69 K, a 39.93% change year over year.
Competitors
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Siemens Healthineers AG
USD 56.32
SHL.DE
+0.05
0.09%
Regeneron Pharmaceuticals, Inc.
USD 563.10
REGN
-1.54
-0.27%
Key Data
| Date | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses | Revenue | Revenue |
|---|
Competitors
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Siemens Healthineers AG
USD 56.32
SHL.DE
+0.05
0.09%
Regeneron Pharmaceuticals, Inc.
USD 563.10
REGN
-1.54
-0.27%